Free Trial

Intellia Therapeutics (NTLA) Insider Trading & Ownership

Intellia Therapeutics logo
$13.38 +0.48 (+3.72%)
(As of 12/16/2024 ET)

Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$1.09 M
Get NTLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NTLA Insider Buying and Selling by Quarter

Intellia Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.12  
7/1/2024Eliana ClarkEVPSell405$22.93$9,286.65  
3/4/2024James BastaEVPSell2,297$32.99$75,778.03  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.25  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.78  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.90  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58  
(Data available from 1/1/2013 forward)

NTLA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Intellia Therapeutics includes David Lebwohl, Eliana Clark, Glenn Goddard, James Basta, John M Leonard, Laura Sepp-Lorenzino, Michael P Dube, and Muna Bhanji. Learn more on insiders at NTLA.

3.20% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings.

The following insiders have sold NTLA shares in the last 24 months: David Lebwohl ($172,134.78), Eliana Clark ($248,870.25), Glenn Goddard ($248,361.57), James Basta ($75,778.03), John M Leonard ($814,611.91), Laura Sepp-Lorenzino ($159,001.93), Michael P Dube ($38,248.12), and Muna Bhanji ($90,924.05).

Insiders have sold a total of 56,785 Intellia Therapeutics shares in the last 24 months for a total of $1,847,930.64 sold.

Intellia Therapeutics Key Executives

  • Dr. John M. Leonard M.D. (Age 67)
    President, CEO & Director
    Compensation: $1.06M
  • Mr. Glenn G. Goddard CPAMr. Glenn G. Goddard CPA (Age 53)
    Executive VP, CFO & Treasurer
    Compensation: $630.91k
  • Dr. Laura Sepp-Lorenzino Ph.D. (Age 63)
    Executive VP & Chief Scientific Officer
    Compensation: $670.58k
  • Mr. James E. Basta Esq. (Age 58)
    J.D., Executive VP, General Counsel & Corporate Secretary
    Compensation: $616.15k
  • Dr. David Lebwohl M.D. (Age 69)
    Executive VP & Chief Medical Officer
    Compensation: $671.42k
  • Mr. Derek Hicks (Age 50)
    Executive VP & Chief Business Officer
    Compensation: $823.42k
  • Mr. Nessan Bermingham Ph.D. (Age 51)
    Founder & Member of Scientific Advisor Board
    Compensation: $1.38M
  • Dr. Rachel E. Haurwitz Ph.D. (Age 38)
    Co-Founder
  • Dr. Andrew May Ph.D.
    Founder and Member of Scientific Advisor Board
  • Dr. Jennifer A. Doudna Ph.D. (Age 60)
    Founder & Member of Scientific Advisor Board


This page (NASDAQ:NTLA) was last updated on 12/16/2024 by MarketBeat.com Staff
From Our Partners